BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8389344)

  • 41. Antigen presentation of herpes simplex virus by corneal epithelium--an in vitro and in vivo study.
    Fahy GT; Hooper DC; Easty DL
    Br J Ophthalmol; 1993 Jul; 77(7):440-4. PubMed ID: 8393700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cauterization of central cornea induces recruitment of major histocompatibility complex class II+ Langerhans cells from limbal basal epithelium.
    Chen W; Lin H; Dong N; Sanae T; Liu Z; Yoshitomi T
    Cornea; 2010 Jan; 29(1):73-9. PubMed ID: 19907296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
    Doymaz MZ; Rouse BT
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rose bengal inhibits herpes simplex virus replication in vero and human corneal epithelial cells in vitro.
    Chodosh J; Banks MC; Stroop WG
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2520-7. PubMed ID: 1321799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.
    Osorio Y; Cai S; Hofman FM; Brown DJ; Ghiasi H
    Curr Eye Res; 2004; 29(2-3):145-51. PubMed ID: 15512961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1.
    Beyer CF; Hill JM; Reidy JJ; Beuerman RW
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):925-32. PubMed ID: 2159453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
    Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of Langerhans cells in the central cornea linked to the development of ocular herpes in mice.
    Jager MJ; Bradley D; Atherton S; Streilein JW
    Exp Eye Res; 1992 Jun; 54(6):835-41. PubMed ID: 1325920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease.
    Shimeld C; Whiteland JL; Nicholls SM; Easty DL; Hill TJ
    J Gen Virol; 1996 May; 77 ( Pt 5)():977-85. PubMed ID: 8609495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of adenovirus-induced eye disease in the rabbit model.
    Trousdale MD; Nóbrega R; Wood RL; Stevenson D; dos Santos PM; Klein D; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2740-8. PubMed ID: 7499096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpes simplex virus: molecular biology and the possibility of corneal latency.
    Cook SD; Hill JH
    Surv Ophthalmol; 1991; 36(2):140-8. PubMed ID: 1659745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice.
    Mitchell WJ; Gressens P; Martin JR; DeSanto R
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1201-10. PubMed ID: 8207387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Herpetic imprint on privileged areas of its target organs: local latency and reactivation in herpetic keratitis.
    Gamus D; Romano A
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(1-2):37-40. PubMed ID: 2855657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996.
    Hendricks RL
    Cornea; 1997 Sep; 16(5):503-6. PubMed ID: 9294678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An improved model of recurrent herpetic eye disease in mice.
    Shimeld C; Hill T; Blyth B; Easty D
    Curr Eye Res; 1989 Nov; 8(11):1193-205. PubMed ID: 2558849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Herpetic stromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea.
    Jager MJ; Atherton S; Bradley D; Streilein JW
    Curr Eye Res; 1991; 10 Suppl():69-73. PubMed ID: 1650675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpes simplex virus--induced destructive corneal disease.
    Foster CS
    Eye (Lond); 1989; 3 ( Pt 2)():194-203. PubMed ID: 2559859
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of herpes simplex virus type 1 latency-associated transcripts in corneal cells of inbred mice by in situ hybridization.
    Abghari SZ; Stulting RD; Petrash JM
    Cornea; 1992 Sep; 11(5):433-8. PubMed ID: 1330438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.